POST FORUM SITE
> ATTENDEES​​
> PRESENTERS
> ​INVESTORS
> SPONSORS & SUPPORTERS

ATTENDING COMPANIES in 2019 Include:

3E Bioventures
4BIO Capital
5AM Ventures
AbbVie, Inc.
Abreos Biosciences, Inc.
ACADIA Pharmaceuticals, Inc.
Actinogen Medical Ltd.
Aisling Capital, LLC
Allergan
Alpha Omega LLC
aMoon Fund
ANeuroTech
Angel Investor
Aqua Partners, LLC
ARGO Publishing GmbH
ASDERA
Asklepios Advisors
Astrocyte Pharmaceuticals, Inc.
Atentiv, LLC
Autifony Therapeutics Ltd.
Axim Biotechnologies, Inc.
AZTherapies, Inc.
Bay City Capital, LLC
Bioasis Technologies, Inc.
BioCentury, Inc.
Biocoast Capital
BioElectron Technology Corporation
Biogen
Biomatics Capital
BioMedPartners AG
Bionomics Ltd.
BioScience Managers Pty Ltd.
Biotech Alliances International, Inc.
Blackstone Life Sciences
BlackThorn Therapeutics
Boehringer Ingelheim International GmbH
Boehringer Ingelheim Venture Fund USA, Inc.
Bradley Woods & Co.
BrainScope Company, Inc.
Brainstorm Cell Therapeutics, Inc.
Bridge Valley Venture LLP.
BridgeBio LLC
Broadview Ventures, Inc.
Brock Capital Group LLC
Brookline Capital Markets
Canaccord Genuity LLC
Canopy Health, a Canopy Growth Corporation company
Cantabio Pharmaceuticals, Inc.
Capgenic Advisors
Cato BioVentures
CBT Advisors
Cello Health BioConsulting previously Defined Health
Cerevance, Inc.
ClearView Healthcare Partners
Click Therapeutics, Inc.
Cognition Therapeutics, Inc.
Connecticut Innovations, Inc.
CTI Life Sciences
CV Sciences, Inc.
Diadem Research
Dolby Family Ventures
Eli Lilly and Company
Emerald Health Pharmaceuticals
Engage Therapeutics, Inc.
Evecxia, Inc.
Excellentia Global Partners
Excelyrate Capital, LLP
Fortune Venture Capital
Fraser Finance
FreeMind Group
GCF Family Office
Generations Fund
Global Neurohealth Ventures
H.C. Wainwright & Co., LLC
Harvard Business Review/ Medical Device Online
Iaso Ventures
Image Analysis Group
Infinity Global Capital
INKEF Capital
IPF Partners
J. Goldman & Co., L.P.
Johnson & Johnson Innovation
KalGene Pharmaceuticals, Inc.
Ladenburg, Thalmann & Co., Inc.

Landmark Angels, Inc.
Life Science Angels
LifeArc Seed Fund
LifeSci Advisors
Lilly Asia Ventures
Locust Walk
Longevity Biotech, Inc.
Loop Capital Markets
Lumira Capital
Lysosomal Therapeutics, Inc.
M Ventures
M3 Biotechnology, Inc.
Medivate Partners
Metys Pharmaceuticals AG
Milestone Capital
Mitsui & Co. Global Investment, Ltd.
Momentum Biotech
MP Healthcare Venture Management, Inc.
MyBiogate, Inc.
NEMUS Bioscience, Inc.
NeuroRx, Inc.
Neurotech Reports
Neurotrope BioScience, Inc.
New Science Global Healthcare Fund
NI Research
Noble Life Science Partners
Noble LifeSelect Fund 
Novaremed AG
Novartis Pharma AG
Novo Holdings A/S
Novo Ventures
NSIP LLC
NYU School of Medicine
Oppenheimer & Co. Inc.
OrbiMed Advisors LLC
Oryzon Genomics S.A.
Oscine Therapeutics
Palo Alto Investors
Panakes Partners SBMT SpA
Pax Neuroscience, Inc.
Pfizer, Inc.
Pharmaleads SA
Philimmune, LLC
PJT Partners
Plich Advisory & Investments B.V.
Profound Ventures
ProMIS™ Neurosciences, Inc.
Purdue Pharma L.P.
Qynapse
Raglan Capital
RBC Capital Markets
Regenera Pharma Ltd.
Relmada Therapeutics, Inc.
Samsung Ventures America
Sanofi
Serina Therapeutics, Inc.
Seva Venture Capital
Silicon Valley Bank
Simcere of America
Snow Lake Capital
Society for Brain Mapping and Therapeutics (SBMT)
Stalicla SA
SternAegis Ventures
Stifel Financial Corp.
Strategic Swiss Partners GmbH
Syndesi Therapeutics SA
T3D Therapeutics, Inc.
TiVenture
Tonix Pharmaceuticals Holding Corp.
Two Sigma Ventures
UCB Pharma
UCLA Technology Development Group
V-Bio Ventures
Valor Management SA
Varana Capital
Vista Point Capital
Vitality Biopharma, Inc.
Vogel BioC
WBB Securities, LLC
WG Partners LLP
WRF (Washington Research Foundation) Capital
Xeraya Capital
Yumanity Therapeutics

*Updated on 21.12.2018